Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07718009

Effects of Alternating Altitude Training Versus Fixed-Altitude Training on Exercise Capacity and Physiological Adaptations in Elite Race Walkers: A Randomized Controlled Trial

This randomized controlled trial aims to compare the effects of alternating altitude training and fixed-altitude training on physical performance and physiological adaptations in elite race walkers living at altitude. Elite race walkers from Yunnan Province will be randomly assigned to either an alternating altitude training group or a fixed-altitude training group. The alternating altitude training group will perform selected training sessions under simulated higher-altitude conditions while completing the remaining sessions at their regular altitude training base. The fixed-altitude training group will complete all training sessions at the regular altitude. Physical performance, race walking performance, cardiovascular function, pulmonary function, and hematological parameters will be assessed before and after the intervention to evaluate the effectiveness of the two altitude training strategies.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–26 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Macao Polytechnic University, Faculty of Health Sciences and Sports, Macao, China

Macao, China

Location status: Recruiting

Location contact

Chaoran Han

CONTACT

[email protected]

+853 8591 2000

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female elite race walkers aged 16-26 years. Registered athletes from the Yunnan Provincial Race Walking Team. Long-term residents of high-altitude regions with regular altitude training experience.

Healthy and medically cleared to participate in high-intensity training and hypoxic exposure.

Able to complete the prescribed training program and all outcome assessments. Provided written informed consent before enrollment. For participants younger than 18 years, written informed consent will also be obtained from a parent or legal guardian.

Exclusion criteria

  • Any cardiovascular, respiratory, metabolic, neurological, or other medical condition contraindicating exercise or hypoxic exposure.

Musculoskeletal injury or illness affecting normal training or performance within the previous three months.

Current use of medications or supplements that may substantially influence physiological adaptation or exercise performance.

Failure to complete the intervention or outcome assessments according to the study protocol.

Withdrawal of informed consent at any time during the study.

Treatment and study plan

Alternating Altitude Training

Behavioral

Participants complete the prescribed training program using an alternating altitude strategy, combining regular altitude training with selected sessions performed under simulated higher-altitude conditions.

Fixed-Altitude Training

Behavioral

Participants complete the prescribed training program exclusively at the regular altitude training base.

Primary outcomes

  1. Body Weight

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Body weight measured before and after the training period.

  2. Body Fat Percentage

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Body fat percentage measured using bioelectrical impedance or other validated method.

  3. Forced Vital Capacity (FVC)

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Forced vital capacity measured using spirometry before and after the intervention.

  4. Maximal Voluntary Ventilation

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    MVV measured using standard pulmonary function testing protocol pre- and post-intervention.

  5. Left Ventricular Volume

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Echocardiography measurement of left ventricular end-diastolic and end-systolic volume.

  6. Ejection Fraction

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Echocardiography assessment of left ventricular ejection fraction pre- and post-training.

  7. Myocardial Thickness

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Measurement of interventricular septum and left ventricular posterior wall thickness by echocardiography.

  8. Maximal Oxygen Uptake

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Pre- and post-intervention measurement of VO₂max using standard exercise testing protocol to assess aerobic capacity

  9. Countermovement Jump Height

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Countermovement jump (CMJ) height measured using a validated force platform or jump assessment system to evaluate lower-limb explosive power before and after the intervention.

  10. Squat Jump Height

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Squat jump (SJ) height measured using a validated force platform or jump assessment system to assess concentric lower-limb explosive strength before and after the intervention.

  11. Isometric Mid-Thigh Pull Peak Force

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Peak force during the isometric mid-thigh pull (IMTP) measured using a force platform to assess maximal isometric lower-limb strength before and after the intervention.

  12. Isometric Mid-Thigh Pull Rate of Force Development

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Rate of force development (RFD) during the isometric mid-thigh pull (IMTP) measured using a force platform before and after the intervention.

  13. Reactive Strength Index (RSI)

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Reactive Strength Index (RSI) calculated from repeated ankle hops using a force platform or validated jump assessment system to assess lower-limb reactive strength before and after the intervention.

Secondary outcomes

  1. Red Blood Cell Count

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    RBC count measured from venous blood samples pre- and post-intervention.

  2. Hemoglobin

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Hemoglobin concentration measured from venous blood samples.

  3. Hematocrit

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Hemoglobin concentration measured from venous blood samples.

  4. Erythropoietin

    Time frame: Baseline and immediately after completion of the 4-week intervention.

    Plasma EPO concentration measured from venous blood samples.

Study contacts

Contact information is provided by the study sponsor or research team.

Binghong Gao

CONTACT

[email protected]

+853 8591 2000

Sponsors and collaborators

Lead sponsor

Macao Polytechnic University

Other

Registry information

Official study title

Effects of Alternating Altitude Training Versus Fixed-Altitude Training on Physical Performance and Physiological Adaptations in Elite Race Walkers: A Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 21, 2026
Registry last updated
Jul 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.